These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20615668)

  • 1. Subjective awareness of tardive dyskinesia and insight in schizophrenia.
    Emsley R; Niehaus DJ; Oosthuizen PP; Koen L; Chiliza B; Fincham D
    Eur Psychiatry; 2011; 26(5):293-6. PubMed ID: 20615668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of awareness of dyskinesia in schizophrenia to insight into mental illness.
    Arango C; Adami H; Sherr JD; Thaker GK; Carpenter WT
    Am J Psychiatry; 1999 Jul; 156(7):1097-9. PubMed ID: 10401460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
    Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
    World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
    Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tardive dyskinesia and positive and negative symptoms of schizophrenia. A study using instrumental measures.
    Yuen O; Caligiuri MP; Williams R; Dickson RA
    Br J Psychiatry; 1996 Jun; 168(6):702-8. PubMed ID: 8773812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine efficacy in tardive dyskinesia in schizophrenic patients.
    Bassitt DP; Louzã Neto MR
    Eur Arch Psychiatry Clin Neurosci; 1998; 248(4):209-11. PubMed ID: 9810484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
    Gharabawi GM; Bossie CA; Lasser RA; Turkoz I; Rodriguez S; Chouinard G
    Schizophr Res; 2005 Sep; 77(2-3):119-28. PubMed ID: 15913963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosocial Implications of Tardive Dyskinesia in Patients With Mood Disorders Versus Schizophrenia.
    McEvoy JP
    J Clin Psychiatry; 2019 Dec; 80(6):. PubMed ID: 31846247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.
    Emsley R; Turner HJ; Schronen J; Botha K; Smit R; Oosthuizen PP
    J Clin Psychiatry; 2004 May; 65(5):696-701. PubMed ID: 15163258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness of tardive dyskinesia in Asian patients with schizophrenia.
    Chong SA; Remington G; Mahendran R; Chua HC
    J Clin Psychopharmacol; 2001 Apr; 21(2):235-7. PubMed ID: 11270922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tardive dyskinesia. Patients' lack of awareness of movement disorder.
    Macpherson R; Collis R
    Br J Psychiatry; 1992 Jan; 160():110-2. PubMed ID: 1347479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Patient knowledge regarding tardive dyskinesia].
    Haberfellner EM; Rittmannsberger H
    Nervenarzt; 2006 Mar; 77(3):333-7. PubMed ID: 16552613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of negative symptoms with tardive dyskinesia in schizophrenic patients.
    Chiu H; Lau J; Lam L; Shum P
    Aust N Z J Psychiatry; 1993 Jun; 27(2):228-32. PubMed ID: 8103320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tardive dyskinesia and dementia.
    Famuyiwa OO; Eccleston D; Donaldson AA; Garside RF
    Br J Psychiatry; 1979 Dec; 135():500-4. PubMed ID: 43754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
    Zhang XY; Zhou DF; Cao LY; Chen DC; Zhu FY; Wu GY
    Schizophr Res; 2003 Aug; 62(3):245-50. PubMed ID: 12837521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia and type II schizophrenia.
    Davis EJ; Borde M; Sharma LN
    Br J Psychiatry; 1992 Feb; 160():253-6. PubMed ID: 1347240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesia.
    Adelufosi AO; Abayomi O; Ojo TM
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010501. PubMed ID: 25866243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.